Hu MY - Search Results

1

Co-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure.

Li F, Zhang M, Xu D, Liu C, Zhong ZY, Jia LL, Hu MY, Yang Y, Liu L, Liu XD. Li F, et al. Among authors: hu my. Acta Pharmacol Sin. 2014 Jun;35(6):792-805. doi: 10.1038/aps.2014.24. Acta Pharmacol Sin. 2014. PMID: 24902787 Free PMC article.

2

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

Xu D, Li F, Zhang M, Zhang J, Liu C, Hu MY, Zhong ZY, Jia LL, Wang DW, Wu J, Liu L, Liu XD. Xu D, et al. Among authors: hu my. Acta Pharmacol Sin. 2014 Sep;35(9):1215-25. doi: 10.1038/aps.2014.39. Epub 2014 Aug 25. Acta Pharmacol Sin. 2014. PMID: 25152023 Free PMC article.

3

Combined Contribution of Increased Intestinal Permeability and Inhibited Deglycosylation of Ginsenoside Rb1 in the Intestinal Tract to the Enhancement of Ginsenoside Rb1 Exposure in Diabetic Rats after Oral Administration.

Liu C, Hu M, Guo H, Zhang M, Zhang J, Li F, Zhong Z, Chen Y, Li Y, Xu P, Li J, Liu L, Liu X. Liu C, et al. Drug Metab Dispos. 2015 Nov;43(11):1702-10. doi: 10.1124/dmd.115.064881. Epub 2015 Aug 11. Drug Metab Dispos. 2015. PMID: 26265741

4

Decreased exposure of atorvastatin in diabetic rats partly due to induction of hepatic Cyp3a and Oatp2.

Shu N, Hu M, Liu C, Zhang M, Ling Z, Zhang J, Xu P, Zhong Z, Chen Y, Liu L, Liu X. Shu N, et al. Xenobiotica. 2016 Oct;46(10):875-81. doi: 10.3109/00498254.2016.1141437. Epub 2016 Feb 10. Xenobiotica. 2016. PMID: 26864241

5

The enhanced atorvastatin hepatotoxicity in diabetic rats was partly attributed to the upregulated hepatic Cyp3a and SLCO1B1.

Shu N, Hu M, Ling Z, Liu P, Wang F, Xu P, Zhong Z, Sun B, Zhang M, Li F, Xie Q, Liu X, Liu L. Shu N, et al. Sci Rep. 2016 Sep 14;6:33072. doi: 10.1038/srep33072. Sci Rep. 2016. PMID: 27624558 Free PMC article.

6

Association of GLP-1 secretion with anti-hyperlipidemic effect of ginsenosides in high-fat diet fed rats.

Liu C, Hu MY, Zhang M, Li F, Li J, Zhang J, Li Y, Guo HF, Xu P, Liu L, Liu XD. Liu C, et al. Among authors: hu my. Metabolism. 2014 Oct;63(10):1342-51. doi: 10.1016/j.metabol.2014.06.015. Epub 2014 Jun 22. Metabolism. 2014. PMID: 25060691

7

Increased glucagon-like peptide-1 secretion may be involved in antidiabetic effects of ginsenosides.

Liu C, Zhang M, Hu MY, Guo HF, Li J, Yu YL, Jin S, Wang XT, Liu L, Liu XD. Liu C, et al. Among authors: hu my. J Endocrinol. 2013 Apr 15;217(2):185-96. doi: 10.1530/JOE-12-0502. Print 2013 May. J Endocrinol. 2013. PMID: 23444389

8

Aggravation of clozapine-induced hepatotoxicity by glycyrrhetinic acid in rats.

Jia LL, Zhong ZY, Li F, Ling ZL, Chen Y, Zhao WM, Li Y, Jiang SW, Xu P, Yang Y, Hu MY, Liu L, Liu XD. Jia LL, et al. Among authors: hu my. J Pharmacol Sci. 2014;124(4):468-79. doi: 10.1254/jphs.13257fp. J Pharmacol Sci. 2014. PMID: 24739264 Free article.

9

High-fat diet enhanced retinal dehydrogenase activity, but suppressed retinol dehydrogenase activity in liver of rats.

Zhang M, Liu C, Hu MY, Zhang J, Xu P, Li F, Zhong ZY, Liu L, Liu XD. Zhang M, et al. Among authors: hu my. J Pharmacol Sci. 2015 Apr;127(4):430-8. doi: 10.1016/j.jphs.2015.03.001. Epub 2015 Mar 7. J Pharmacol Sci. 2015. PMID: 25953270 Free article.

10

A mechanistic physiologically based pharmacokinetic-enzyme turnover model involving both intestine and liver to predict CYP3A induction-mediated drug-drug interactions.

Guo H, Liu C, Li J, Zhang M, Hu M, Xu P, Liu L, Liu X. Guo H, et al. J Pharm Sci. 2013 Aug;102(8):2819-36. doi: 10.1002/jps.23613. Epub 2013 Jun 11. J Pharm Sci. 2013. PMID: 23760985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page